| PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.848 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.848 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.848 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.848 |
Evidence |
|